Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: One-year interim results of SPACE-2

Background Treatment of individuals with asymptomatic carotid artery stenosis is still handled controversially. Recommendations for treatment of asymptomatic carotid stenosis with carotid endarterectomy (CEA) are based on trials having recruited patients more than 15 years ago. Registry data indicate that advances in best medical treatment (BMT) may lead to a markedly decreasing risk of stroke in asymptomatic carotid stenosis. The aim of the SPACE-2 trial (ISRCTN78592017) was to compare the stroke preventive effects of BMT alone with that of BMT in combination with CEA or carotid artery stenting (CAS), respectively, in patients with asymptomatic carotid artery stenosis of ≥70% European Carotid Surgery Trial (ECST) criteria. Methods SPACE-2 is a randomized, controlled, multicenter, open study. A major secondary endpoint was the cumulative rate of any stroke (ischemic or hemorrhagic) or death from any cause within 30 days plus an ipsilateral ischemic stroke within one year of follow-up. Safety was assessed as the rate of any stroke and death from any cause within 30 days after CEA or CAS. Protocol changes had to be implemented. The results on the one-year period after treatment are reported. Findings It was planned to enroll 3550 patients. Due to low recruitment, the enrollment of patients was stopped prematurely after randomization of 513 patients in 36 centers to CEA (n = 203), CAS (n = 197), or BMT (n = 113). The one-year rate of the major secondary endpoint did not significantly differ between groups (CEA 2.5%, CAS 3.0%, BMT 0.9%; p = 0.530) as well as rates of any stroke (CEA 3.9%, CAS 4.1%, BMT 0.9%; p = 0.256) and all-cause mortality (CEA 2.5%, CAS 1.0%, BMT 3.5%; p = 0.304). About half of all strokes occurred in the peri-interventional period. Higher albeit statistically non-significant rates of restenosis occurred in the stenting group (CEA 2.0% vs. CAS 5.6%; p = 0.068) without evidence of increased stroke rates. Interpretation The low sample size of this prematurely stopped trial of 513 patients implies that its power is not sufficient to show that CEA or CAS is superior to a modern medical therapy (BMT) in the primary prevention of ischemic stroke in patients with an asymptomatic carotid stenosis up to one year after treatment. Also, no evidence for differences in safety between CAS and CEA during the first year after treatment could be derived. Follow-up will be performed up to five years. Data may be used for pooled analysis with ongoing trials.

[1]  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. , 1995, JAMA.

[2]  R. Peto,et al.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial , 2004, The Lancet.

[3]  Stephen P. Lownie,et al.  Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis , 2005, Stroke.

[4]  A. Algra,et al.  Asymptomatic Carotid Artery Stenosis and the Risk of New Vascular Events in Patients With Manifest Arterial Disease: The SMART Study , 2007, Stroke.

[5]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[6]  O. Wagner,et al.  Progression of Carotid Stenosis Detected by Duplex Ultrasonography Predicts Adverse Outcomes in Cardiovascular High-Risk Patients , 2007, Stroke.

[7]  M. Hartmann,et al.  Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study , 2008, The Lancet Neurology.

[8]  Erik Buskens,et al.  Prevalence of Asymptomatic Carotid Artery Stenosis According to Age and Sex: Systematic Review and Metaregression Analysis , 2009, Stroke.

[9]  W. Hacke,et al.  Stent-Protected Angioplasty in Asymptomatic Carotid Artery Stenosis vs. Endarterectomy: SPACE2 – a Three-Arm Randomised-Controlled Clinical Trial , 2009, International journal of stroke : official journal of the International Stroke Society.

[10]  P A Gaines,et al.  Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  A. Abbott,et al.  Medical (Nonsurgical) Intervention Alone Is Now Best for Prevention of Stroke Associated With Asymptomatic Severe Carotid Stenosis: Results of a Systematic Review and Analysis , 2009, Stroke.

[12]  R. Peto,et al.  10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial , 2010, Lancet.

[13]  N. Bornstein,et al.  Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study , 2010, The Lancet Neurology.

[14]  J. Ricco,et al.  Asymptomatic carotid artery stenosis--medical therapy alone versus medical therapy plus carotid endarterectomy or stenting. , 2010, Journal of vascular surgery.

[15]  P. Rothwell Carotid stenting: more risky than endarterectomy and often no better than medical treatment alone , 2010, The Lancet.

[16]  B. Widder,et al.  [Revision of DEGUM ultrasound criteria for grading internal carotid artery stenoses and transfer to NASCET measurement]. , 2010, Ultraschall in der Medizin.

[17]  P. Rothwell,et al.  Low Risk of Ipsilateral Stroke in Patients With Asymptomatic Carotid Stenosis on Best Medical Treatment: A Prospective, Population-Based Study , 2010, Stroke.

[18]  Michael D Hill,et al.  Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.

[19]  Erik Buskens,et al.  Prevalence of Asymptomatic Carotid Artery Stenosis in the General Population: An Individual Participant Data Meta-Analysis , 2010, Stroke.

[20]  Robert A Hegele,et al.  Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. , 2010, Archives of neurology.

[21]  B. Widder,et al.  Ultraschallkriterien zur Graduierung von Stenosen der A. carotis interna – Revision der DEGUM-Kriterien und Transfer in NASCET-Stenosierungsgrade , 2010 .

[22]  George Howard,et al.  Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) , 2011, Stroke.

[23]  G. Fraedrich,et al.  Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis--a pooled analysis of EVA-3S, SPACE and ICSS. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[24]  J. Halperin,et al.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. , 2011, Stroke.

[25]  Y. Kuo,et al.  Outcomes After Carotid Artery Stenting and Endarterectomy in the Medicare Population , 2011, Stroke.

[26]  H. Eckstein Evidence-based management of carotid stenosis: recommendations from international guidelines. , 2012, The Journal of cardiovascular surgery.

[27]  G. Hubermont,et al.  The challenging topic of diabetic foot revascularization: does the angiosome-guided angioplasty may improve outcome. , 2012, The Journal of cardiovascular surgery.

[28]  A. Algra,et al.  Asymptomatic Carotid Artery Stenosis and the Risk of Ischemic Stroke According to Subtype in Patients With Clinical Manifest Arterial Disease , 2013, Stroke.

[29]  R. Cambria,et al.  Progression of asymptomatic carotid stenosis despite optimal medical therapy. , 2012, Journal of vascular surgery.

[30]  M. Silvestrini,et al.  One-Year Progression of Moderate Asymptomatic Carotid Stenosis Predicts the Risk of Vascular Events , 2013, Stroke.

[31]  Daniel J. Bertges,et al.  Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. , 2013, Journal of vascular surgery.

[32]  A. Hartog,et al.  Asymptomatic Carotid Artery Stenosis and the Risk of Ischemic Stroke According to Subtype in Patients With Clinical Manifest Arterial Disease , 2013 .

[33]  E. Falk,et al.  Stabilization of atherosclerotic plaques: an update. , 2013, European heart journal.

[34]  W. Hacke,et al.  Modification of SPACE-2 Study Design , 2014, International journal of stroke : official journal of the International Stroke Society.

[35]  D. Pelz,et al.  Asymptomatic carotid stenosis: identifying patients at high enough risk to warrant endarterectomy or stenting. , 2014, Stroke.

[36]  A. Nicolaides,et al.  Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. , 2014, Journal of vascular surgery.

[37]  L. Hirt Progression Rate and Ipsilateral Neurological Events in Asymptomatic Carotid Stenosis , 2014, Stroke.

[38]  E. Feldmann,et al.  Asymptomatic Carotid Artery Stenosis Treated with Medical Therapy Alone: Temporal Trends and Implications for Risk Assessment and the Design of Future Studies , 2014, Cerebrovascular Diseases.

[39]  M. Fornage,et al.  Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[40]  J. Mandrekar,et al.  Asymptomatic Carotid Stenosis: Risk of Progression and Development of Symptoms , 2015, Cerebrovascular Diseases.

[41]  J. Spence,et al.  Risk of Stroke at the Time of Carotid Occlusion. , 2015, JAMA neurology.

[42]  R. Sacco,et al.  How recent data have impacted the treatment of internal carotid artery stenosis. , 2015, Journal of the American College of Cardiology.

[43]  Marije Bosch,et al.  Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis , 2015, Stroke.

[44]  A. Naylor,et al.  Why is the management of asymptomatic carotid disease so controversial? , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[45]  Robert D. Brown,et al.  The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis , 2016, Neurology.

[46]  W. Hacke,et al.  SPACE-2: A Missed Opportunity to Compare Carotid Endarterectomy, Carotid Stenting, and Best Medical Treatment in Patients with Asymptomatic Carotid Stenoses. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[47]  W. Gray,et al.  Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. , 2016, The New England journal of medicine.

[48]  A. Naylor,et al.  Stroke/Death Rates Following Carotid Artery Stenting and Carotid Endarterectomy in Contemporary Administrative Dataset Registries: A Systematic Review. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[49]  B. Dawn,et al.  Optimal Medical Management Reduces Risk of Disease Progression and Ischemic Events in Asymptomatic Carotid Stenosis Patients: A Long-Term Follow-Up Study , 2017, Cerebrovascular Diseases.

[50]  C. Moy,et al.  Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials , 2017, International journal of stroke : official journal of the International Stroke Society.

[51]  J. Spence Asymptomatic carotid stenosis , 2017, Neurology.

[52]  A. Naylor,et al.  Which patients with asymptomatic carotid stenosis benefit from revascularization? , 2017, Current opinion in neurology.

[53]  Sang-Ah Han,et al.  Prevalence and risk factors for atherosclerotic carotid stenosis and plaque , 2017, Medicine.

[54]  M. Björck,et al.  Editor's Choice - Carotid Stenosis Treatment: Variation in International Practice Patterns. , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[55]  M. Secrest,et al.  Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-Analysis , 2017, Stroke.

[56]  A. Stella,et al.  The fate of asymptomatic severe carotid stenosis in the era of best medical therapy , 2017, Brain injury.

[57]  H S Markus,et al.  Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[58]  A. Algra,et al.  Influence of stent design and use of protection devices on outcome of carotid artery stenting: a pooled analysis of individual patient data , 2018, Journal of NeuroInterventional Surgery.

[59]  F. Veith,et al.  Appropriate Patient Selection for Carotid Revascularization Procedures is Urgently Needed , 2018, Angiology.